(ATR) AptarGroup - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0383361039
ATR: Pumps, Valves, Closures, Dispensers, Inhalers, Elastomers
AptarGroup Inc (NYSE:ATR) stands as a leader in designing and manufacturing advanced solutions for drug delivery, consumer product dispensing, and active material science. Their expertise spans multiple sectors, including pharmaceuticals, beauty, personal care, home care, and food and beverage. Through their segments—Aptar Pharma, Aptar Beauty, and Aptar Closures—they deliver a diverse range of products such as pumps for nasal allergy treatments and metered dose inhaler valves for respiratory conditions like asthma and COPD. Their elastomer solutions are crucial for injectable primary packaging, showcasing their commitment to innovation and quality.
With a strong global presence, AptarGroup serves markets in Asia, Europe, Latin America, and North America. Their headquarters in Crystal Lake, Illinois, has been the hub of their operations since their incorporation in 1992. The companys dedication to R&D and sustainability practices underscores their role as a key player in the supply chain, offering tailored solutions that meet evolving market demands and customer needs.
Investors and fund managers will note AptarGroups financial metrics, which highlight their market position and growth potential. With a market capitalization of $10,410.70 million USD, the company presents a P/E ratio of 31.35 and a forward P/E of 28.74, indicating expectations for continued growth. Their P/B ratio of 4.15 and P/S ratio of 2.91 provide further insight into their valuation, making them a notable consideration for those evaluating industry leaders with a strong financial foundation.
Additional Sources for ATR Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ATR Stock Overview
Market Cap in USD | 9,626m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC Sub-Industry | Metal, Glass & Plastic Containers |
IPO / Inception | 1993-04-21 |
ATR Stock Ratings
Growth 5y | 52.6% |
Fundamental | 56.6% |
Dividend | 55.8% |
Rel. Strength Industry | 9.15 |
Analysts | 4.29/5 |
Fair Price Momentum | 133.65 USD |
Fair Price DCF | 121.36 USD |
ATR Dividends
Dividend Yield 12m | 1.20% |
Yield on Cost 5y | 2.13% |
Annual Growth 5y | 3.62% |
Payout Consistency | 100.0% |
ATR Growth Ratios
Growth Correlation 3m | -75.5% |
Growth Correlation 12m | 64.4% |
Growth Correlation 5y | 53.4% |
CAGR 5y | 12.15% |
CAGR/Max DD 5y | 0.31 |
Sharpe Ratio 12m | 1.22 |
Alpha | -2.18 |
Beta | 0.50 |
Volatility | 24.13% |
Current Volume | 223.6k |
Average Volume 20d | 372.2k |
As of March 15, 2025, the stock is trading at USD 146.66 with a total of 223,585 shares traded.
Over the past week, the price has changed by -4.01%, over one month by +1.29%, over three months by -12.26% and over the past year by +5.28%.
Partly, yes. Based on ValueRay Fundamental Analyses, AptarGroup (NYSE:ATR) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 56.55 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ATR as of March 2025 is 133.65. This means that ATR is currently overvalued and has a potential downside of -8.87%.
AptarGroup has received a consensus analysts rating of 4.29. Therefor, it is recommend to buy ATR.
- Strong Buy: 4
- Buy: 1
- Hold: 2
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, ATR AptarGroup will be worth about 145.4 in March 2026. The stock is currently trading at 146.66. This means that the stock has a potential downside of -0.89%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 177 | 20.7% |
Analysts Target Price | 186.2 | 26.9% |
ValueRay Target Price | 145.4 | -0.9% |